What is the level of liabilities of BioMaxima this year?
BioMaxima has a debt balance of 26.81 M PLN this year.
BioMaxima Liabilities 2025
BioMaxima Liabilities
26.81 M PLN
Ticker
BMX.WA
ISIN
PLBIOMX00015
WKN
A1C5AE
In 2025, BioMaxima's total liabilities amounted to 26.81 M PLN, a 0% difference from the 0 PLN total liabilities in the previous year.
BioMaxima Aktienanalyse
What does BioMaxima do?
BioMaxima ist eines der beliebtesten Unternehmen auf Eulerpool.com.Liabilities Details
Assessing BioMaxima's Liabilities
BioMaxima's liabilities constitute the company's financial obligations and debts owed to external parties and stakeholders. They are categorized into current liabilities, due within a year, and long-term liabilities, which are due over a longer period. A detailed assessment of these liabilities is crucial for evaluating BioMaxima's financial stability, operational efficiency, and long-term viability.
Year-to-Year Comparison
By comparing BioMaxima's liabilities year-over-year, investors can identify trends, shifts, and anomalies in the company’s financial positioning. A decrease in total liabilities often signals financial strengthening, while an increase might indicate enhanced investments, acquisitions, or potential financial strain.
Impact on Investments
BioMaxima's total liabilities play a significant role in determining the company's leverage and risk profile. Investors and analysts examine this aspect meticulously to ascertain the firm’s ability to meet its financial obligations, which influences investment attractiveness and credit ratings.
Interpreting Liability Fluctuations
Shifts in BioMaxima’s liability structure indicate changes in its financial management and strategy. A reduction in liabilities reflects efficient financial management or debt payoffs, while an increase may suggest expansion, acquisition activities, or accruing operational expenses, each carrying distinct implications for investors.
Frequently Asked Questions about BioMaxima stock
What were the liabilities of BioMaxima compared to the previous year?
The liabilities of BioMaxima have increased by 0% increased compared to the previous year.
What are the consequences of high debt for investors of BioMaxima?
High liabilities can pose a risk for investors of BioMaxima, as they can weaken the company's financial position and impair its ability to meet its obligations.
What consequences do low liabilities have for investors in BioMaxima?
Low liabilities mean that BioMaxima has a strong financial position and is able to meet its obligations without overburdening its finances.
How does an increase in liabilities of BioMaxima affect the company?
An increase in liabilities of BioMaxima can lead to the company having more obligations and potentially find it more difficult to meet its financial commitments.
How does a reduction in the liabilities of BioMaxima affect the company?
A decrease in the liabilities of BioMaxima can lead to the company having fewer obligations and a stronger financial position, which can make it easier for the company to fulfill its financial commitments.
What are some factors that influence the liabilities of BioMaxima?
Some factors that can influence the liabilities of BioMaxima include investments, acquisitions, operating costs, and sales development.
Why is the level of liabilities of BioMaxima so important for investors?
The liabilities of BioMaxima are important for investors as they serve as an indicator of the company's financial stability and provide investors with information on how the company meets its financial obligations.
What strategic measures can BioMaxima take to modify the liabilities?
To change its liabilities, BioMaxima can take measures such as cost savings, increasing revenue, selling assets, raising investments, or forming partnerships. It is important for the company to conduct a thorough review of its financial situation to choose the best strategic actions.
How much dividend does BioMaxima pay?
Over the past 12 months, BioMaxima paid a dividend of 0.5 PLN . This corresponds to a dividend yield of about 4.35 %. For the coming 12 months, BioMaxima is expected to pay a dividend of 0.5 PLN.
What is the dividend yield of BioMaxima?
The current dividend yield of BioMaxima is 4.35 %.
When does BioMaxima pay dividends?
BioMaxima pays a quarterly dividend. This is distributed in the months of September, June, July, July.
How secure is the dividend of BioMaxima?
BioMaxima paid dividends every year for the past 3 years.
What is the dividend of BioMaxima?
For the upcoming 12 months, dividends amounting to 0.5 PLN are expected. This corresponds to a dividend yield of 4.35 %.
In which sector is BioMaxima located?
BioMaxima is assigned to the 'Health' sector.
Wann musste ich die Aktien von BioMaxima kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of BioMaxima from 6/30/2023 amounting to 0.5 PLN, you needed to have the stock in your portfolio before the ex-date on 6/16/2023.
When did BioMaxima pay the last dividend?
The last dividend was paid out on 6/30/2023.
What was the dividend of BioMaxima in the year 2024?
In the year 2024, BioMaxima distributed 0.45 PLN as dividends.
In which currency does BioMaxima pay out the dividend?
The dividends of BioMaxima are distributed in PLN.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
Andere Kennzahlen von BioMaxima
Our stock analysis for BioMaxima Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of BioMaxima Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.